Frankfurt
22.06.26 | 09:08
0,001 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.05. | IN BRIEF: Nuformix interim loss narrows; aims to raise value of assets | 1 | Alliance News | ||
| 28.05. | Nuformix PLC - Half Year Report | - | RNS | ||
| 31.03. | Nuformix PLC - Total Voting Rights | - | RNS | ||
| 11.03. | SMALL-CAP WINNERS & LOSERS: Nuformix down after GBP1.0 million placing | 2 | Alliance News | ||
| 11.03. | Nuformix PLC - £1.0 million Placing | - | RNS | ||
| 10.03. | Nuformix erhält FDA-Orphan-Drug-Status für Behandlung von Lungenfibrose | 1 | Investing.com Deutsch | ||
| NUFORMIX Aktie jetzt für 0€ handeln | |||||
| 10.03. | Nuformix receives FDA orphan drug status for IPF treatment | 1 | Investing.com | ||
| 10.03. | Nuformix PLC - Confirmation of US ODD for NXP002 in IPF | - | RNS | ||
| 03.03. | Nuformix PLC - Result of AGM | - | RNS | ||
| 05.02. | Nuformix PLC - Posting of Annual Report and Notice of AGM | - | RNS | ||
| 27.01. | Nuformix focused on lead asset for pulmonary fibrosis as loss narrows | 1 | Alliance News | ||
| 27.01. | Nuformix PLC - Annual Results for period ended 30 September 2025 | 1 | RNS | ||
| 29.10.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 29.10.2025 | 1.214 | Xetra Newsboard | Das Instrument 1TY NL0013654783 PROSUS NV EO -,05 EQUITY wird cum Kapitalmassnahme gehandelt am 29.10.2025 und ex Kapitalmassnahme am 30.10.2025 The instrument 1TY NL0013654783 PROSUS NV EO -,05 EQUITY... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONANO GENOMICS | 1,155 | +1,32 % | Bionano Genomics: Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption | SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 10,650 | +1,96 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA, Expanding Total Commercial Coverage to ~52 Million U.S. Lives | Agreement with second leading group purchasing organization (GPO), effective June 1, 2026, provides access to approximately 17 million additional U.S. commercial lives (10% of the ~177 million commercial... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,010 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| PSYCHED WELLNESS | 0,007 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Provides Corporate Update | Toronto, Ontario--(Newsfile Corp. - June 10, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production... ► Artikel lesen | |
| JAGUAR HEALTH | 2,400 | +6,67 % | Jaguar Health, Inc.: Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program | Reminder: Lisa Conte, Jaguar's founder & CEO, to present on June 24, 2026 at the Life Sciences Virtual Investor Forum to provide updates on company's crofelemer development program for rare intestinal... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,005 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2026ISIN NameAU000000BMG3 BMG... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,033 | 0,00 % | BetterLife Pharma Inc.: BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing | Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") today announced it has closed a CAD... ► Artikel lesen | |
| MEDIPHARM LABS | 0,040 | -11,11 % | MediPharm Labs Corp.: MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders | TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,019 | 0,00 % | Promino Nutritional Sciences, Inc.: Promino Expands U.S. NCAA Athlete Platform with Multi-Sport NIL Agreement with Every True Tiger | Promino expands its U.S. NCAA NIL platform with Every True Tiger, the third-party marketing arm of the Missouri Tigers, and select student-athletes across leading sports, including football, basketball... ► Artikel lesen | |
| ADDEX THERAPEUTICS | 0,048 | 0,00 % | Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026 | Geneva, Switzerland, June 22, 2026
-
Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,013 | -61,76 % | ARGENT BIOPHARMA LIMITED: Long Term Aquiol Licensing and Supply Agreement | ||
| CANNABIST COMPANY | 0,020 | 0,00 % | Cannabist Company Holdings Inc (The): Cannabist Company Holdings to be delisted from Cboe | ||
| IANTHUS CAPITAL | 0,001 | -93,55 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Fiscal First Quarter 2026 Financial Results | NEW YORK and TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen | |
| CENTR BRANDS | 0,001 | 0,00 % | Centr Brands Corp (2): Centr Brands closes $100,000 debenture financing |
NUFORMIX PLC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NUFORMIX PLC finden Sie auf Wallstreet Online.